Harrisburg Daily Digest
SEE OTHER BRANDS

The latest news from Pennsylvania

Harrisburg Daily Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.

Press releases published on June 11, 2025

Mark L. Mattioli and Beth Anne Jackson Appointed as Co-Chairs of Post & Schell’s Health Care Practice Group

Mark L. Mattioli and Beth Anne Jackson Appointed as Co-Chairs of Post & Schell’s Health Care Practice Group

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Post …

Majority of Diagnostic Laboratory Leaders Bet Big on Digital Pathology and AI

Majority of Diagnostic Laboratory Leaders Bet Big on Digital Pathology and AI

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to advancing precision medicine. This perspective comes as organizations across the sector prioritize …

Windtree Receives Offer for Its Preclinical Oncology Drug Candidate

Windtree Receives Offer for Its Preclinical Oncology Drug Candidate

Company to receive $7.0 million up front for its  preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to $1.5 billion over the life of the drug …

FS-Elliott Expands Manufacturing & Service Programs to Maximize Customer Uptime

FS-Elliott Expands Manufacturing & Service Programs to Maximize Customer Uptime

Accelerated Repairs, On-Demand Storage, and Smarter Manufacturing to Keep Operations Running EXPORT, PA, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- FS-Elliott, a leading manufacturer of centrifugal air and gas compressors, announces a series of …

Ocugen To Present at BIO International Convention 2025

Ocugen To Present at BIO International Convention 2025

MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present at the 2025 BIO International …

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement- -Out of Network reimbursement is only the first step towards expanding third-party …

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages them to take control of their health …

Cabaletta Bio Announces Proposed Public Offering of Securities

Cabaletta Bio Announces Proposed Public Offering of Securities

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the follow-up period in all responding patients – – All SLE …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service